AcquisitionsJun 9, 2026, 03:31 PM
Tevogen Bio evaluates MSO/CRO acquisitions for $100M annual revenue
AI Summary
Tevogen Bio Holdings Inc. announced the formation of a new healthcare services initiative, led on an interim basis by William Keane, Vice President of Strategic Initiatives. This initiative includes the evaluation of potential acquisitions of a Management Services Organization (MSO) and a Contract Research Organization (CRO). These acquisitions are projected to generate approximately $100 million in combined annual revenue, supporting the company's evolution into a broader healthcare enterprise and its mission to enhance affordability and access.
Key Highlights
- Tevogen Bio forms a new healthcare services initiative to expand into a broader, revenue-generating enterprise.
- Company is evaluating potential acquisitions of a Management Services Organization (MSO) and a Contract Research Organization (CRO).
- Potential acquisitions could contribute approximately $100 million in combined annual revenue.
- William Keane, VP of Strategic Initiatives, is appointed interim head of the healthcare services initiative.
- The initiative aims to support long-term financial self-sufficiency and improve healthcare affordability and access.
Price Impact
More from TVGN